DR. EDGAR PÉREZ BARRAGÁN


Education:

  • 2017 – Training Stay at the HIV Unit and Infectious Diseases Unit. University Hospital 12 de Octubre.
  • 2018 – Subspecialty in Infectious Diseases. Hospital de Infectología, National Medical Center “La Raza”, IMSS.
  • 2016 – Specialty in Internal Medicine. Hospital de Especialidades “Adolfo Ruiz Cortines” IMSS.
  • 2010 – Bachelor’s Degree in Medicine and Surgery, Autonomous University Benito Juárez de Oaxaca.

Academic appointments: 

  • Project Director of the Society for Research and Teaching in Virology and Infectious Diseases (SIDVI).
  • Affiliated Researcher at CISIDAT.

Research interests:

  • HIV and comorbidities.
  • MPOX.
  • COVID-19.
  • Hepatitis C.

Featured projects:

  • Physician attached to the Infectious Diseases service of the Specialized Clinic Condesa Iztapalapa, CDMX.
  • Physician attached to the Infectious Diseases service of the Infectious Diseases Hospital of the National Medical Center “La Raza” IMSS.
  • Infectious Disease Physician and Member of the advisory board of Hospital Ángeles Roma, CDMX.

SELECTED PUBLICATIONS

  • Pérez-Barragán E, Castillo-Flores JH, Mata-Marín JA, et al. COVID-19 in people living with HIV: a single-center descriptive study. J Infect Dev Ctries. 2022 Dec 31;16(12):1796-1799.
  • Pérez-Cavazos S, Pérez-Barragán E. Human mpox (formerly monkeypox): The New Great Imitator?. Am J Trop Med Hyg. 2022 Dec 12:tpmd220509. doi: 10.4269/ajtmh.22-0509.
  • Pérez-Barragán E, Pérez-Cavazos S. First case report of human monkeypox in Latin America: The beginning of a new outbreak. J Infect Public Health. 2022 Oct 12;15(11):1287-1289.
  • Mata-Marín JA, de Pablos-Leal AA, Mauss S, et al. Risk factors for HCV transmission in HIV-positive men who have sex with men in México. PLoS One. 2022 Jul 15;17(7):e0269977
  • Perez-Nieto OR, Escarraman-Martinez D, Guerrero-Gutierrez MA, et al. Awake prone positioning and oxygen therapy in patients with COVID-19: the APRONOX study. Eur Respir J. 2022 Feb 24;59(2):2100265.
  • Bautista-Martínez JS, Mata-Marín JA, Sandoval-Ramírez JL, et al. Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy. Pharmacogenetics and Genomics: October 22, 2021
  • Luis Cárdenas-Bravo, Alfredo Cabrera-Rayo, Edgar Pérez-Barragán, et al. Recursos diagnósticos en la infección por SARS-CoV-2. Med Int Méx. 2020;36(Suplemento 2):S35-S40.
  • Márquez-Díaz F, Rojas-Flores DM, Cárdenas-Bravo L, et al. Posición del Colegio de Medicina Interna de México acerca del nuevo coronavirus, 2019. Med Int Méx. 2020 enero febrero;36(1):87-93
  • Pérez-Barragán E, Sandino Pérez J, Corbella L, et al. Achromobacter xylosoxidans bacteraemia: a single-centre case series. Rev Esp Quimioter. 2018 Jun; 31(3): 268–273.
  • Sandino Pérez J, Mancilla AM, Pérez Barragán E, et al. Chryseobacterium bacteraemia: a single-centre case series. Infect Dis (Lond). 2018 Apr 25:1-4